Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Moore

Showing results (141-150 of 235) with videos related to

Pageof 24
Sort By:
The EMBO Journal|December 16, 2000
The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctionsH Le Hir, E Izaurralde, L E Maquat, et al.
Investigational New Drugs|September 18, 1998
A phase II study of temozolomide in advanced untreated pancreatic cancerM J Moore, R Feld, D Hedley, et al.
Cancer Research|November 21, 2000
Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivityD R Rauchwerger, P S Firby, D W Hedley, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1974
Reaginic antibody in experimental allergic encephalomyelitis. I. Characterization of heat-labile skin-fixing antibodyM J Moore, P O Behan, M W Kies, et al.
Acta Neuropathologica|January 1, 1972
Variations in muscle status with age and systemic diseasesJ J Rebeiz, M J Moore, E M Holden, et al.
Plant Disease|February 1, 2019
Inhibition of Ophiognomonia clavigignenti-juglandacearum by Juglans Species Bark ExtractsM J Moore, M E Ostry, A D Hegeman, et al.
Allergie Und Immunologie|January 1, 1983
Depressed macrophage functions at temperatures below 37 degrees CR Ganguly, D Hoover, V Traynelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancerM J Moore, I F Tannock, D S Ernst, et al.
Cancer|August 1, 1978
Bilateral primary germ cell testicular tumors: report of four cases and review of the literatureS Aristizabal, J R Davis, R C Miller, et al.
Clinical Pharmacology and Therapeutics|December 1, 1988
Rapid development of enhanced clearance after high-dose cyclophosphamideM J Moore, R W Hardy, J J Thiessen, et al.
Pageof 24

Showing results (141-150 of 235) with videos related to

Sort By:
Pageof 24
The EMBO Journal|December 16, 2000
The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctionsH Le Hir, E Izaurralde, L E Maquat, et al.
Investigational New Drugs|September 18, 1998
A phase II study of temozolomide in advanced untreated pancreatic cancerM J Moore, R Feld, D Hedley, et al.
Cancer Research|November 21, 2000
Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivityD R Rauchwerger, P S Firby, D W Hedley, et al.
Research Communications in Chemical Pathology and Pharmacology|September 1, 1974
Reaginic antibody in experimental allergic encephalomyelitis. I. Characterization of heat-labile skin-fixing antibodyM J Moore, P O Behan, M W Kies, et al.
Acta Neuropathologica|January 1, 1972
Variations in muscle status with age and systemic diseasesJ J Rebeiz, M J Moore, E M Holden, et al.
Plant Disease|February 1, 2019
Inhibition of Ophiognomonia clavigignenti-juglandacearum by Juglans Species Bark ExtractsM J Moore, M E Ostry, A D Hegeman, et al.
Allergie Und Immunologie|January 1, 1983
Depressed macrophage functions at temperatures below 37 degrees CR Ganguly, D Hoover, V Traynelis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancerM J Moore, I F Tannock, D S Ernst, et al.
Cancer|August 1, 1978
Bilateral primary germ cell testicular tumors: report of four cases and review of the literatureS Aristizabal, J R Davis, R C Miller, et al.
Clinical Pharmacology and Therapeutics|December 1, 1988
Rapid development of enhanced clearance after high-dose cyclophosphamideM J Moore, R W Hardy, J J Thiessen, et al.
Pageof 24